Form 4 for CTSO Cytosorbents Corp
Accepted 2021-09-02 00:00:00 ET · period of report 2021-08-31 · accession 0001104659-21-112499 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-02 | 2021-08-31 | CTSO | Kraus Al | Dir | M - OptEx | $4.13 | +4,000 | 129.0K | +3% | +$16.5K |
| D | 2021-09-02 | 2021-08-31 | CTSO | Kraus Al | Dir | S - Sale+OE | $9.40 | -4,000 | 125.0K | -3% | -$37.6K |
| D | 2021-09-02 | 2021-08-31 | CTSO | Kraus Al | Dir | M - OptEx | $0.00 | -4,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-31 | M | A | 4,000 | $4.13 | 129,046 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-31 | S | D | 4,000 | $9.40 | 125,046 | D | — | — | (F1) Reflects the weighted average price of sales on August 31, 2021. The shares were sold in multiple transactions at prices ranging from $9.38 to $9.409, inclusive. The reporting person undertakes to provide to CytoSorbents Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. (F2) Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control" of the Company as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 55,746 shares of common stock owned by the reporting person. |
| 3 | Derivative | Stock Option (right to buy) | 2021-08-31 | M | D | 4,000 | $0.00 | 0 | D | $4.13 · 2012-01-18 to 2022-01-18 | 4,000 Common Stock |